Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001221508-09-000022
Filing Date
2009-08-21
Accepted
2009-08-21 14:15:24
Documents
4
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-KSB/A2 form10ka2_06302008v2.htm 10-K/A.2 461515
3 EXHIBIT 31.1 exhibit31_1sept2508.htm EX-31.1 4991
4 EXHIBIT 31.2 exhibit31_2sept2508.htm EX-31.2 5004
5 filename5.htm CORRESP 2673
  Complete submission text file 0001221508-09-000022.txt   475988
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-50156 | Film No.: 091028347
SIC: 2834 Pharmaceutical Preparations